Make your money go further for just 25p per day

The week at a glance: 22 July – results madness

26/07/2019 · Alphabet (GOOGL)  · Amazon (AMZN)  · Aston Martin Lagonda (AML)  · AstraZeneca (AZN)  · Burford Capital Ltd (BUR)  · Diageo (DGE)  · Fevertree Drinks (FEVR)  · GSK (GSK)  · Meta Platforms (META)  · Quartix Technologies (QTX)  · Relx (RELX)  · Sage Group (SGE)  · Unilever (ULVR)  · Vodafone (VOD) 

Diageo drinks lined up on the bar

Who says 38-degree heat isn’t the perfect temperature for analysing company results? For those who didn’t quite get round to reading the plethora of numbers, either because they were too busy sweating or because they were fretting about the make-up of Boris Johnson’s new cabinet, here is a run through of the top headlines of the week.


Starting with the US, where the tech giants (largely) continued the run of dominance which has worried regulators. Amazon’s (US: AMZN) interim numbers revealed that the company now has a 49% share of the online retail market in the US. Investors weren’t impressed that it had missed profit expectations owing to its increased investment in one-day delivery, but Kindle’s head of e-commerce Jon Reilly told the BBC that Amazon doesn’t care what Wall Street thinks…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alphabet

Knocking the lights out | China slowdown | Tech beats

31/10/2024 · Portfolio

While the Budget has been uppermost in the minds of many UK investors, particularly those with…


Episode 30 of the Investor’s Champion Podcast

11/08/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Chris and Lee kick off with a…


More on Amazon

Tech giants take a battering - time to buy?

31/10/2022 · Portfolio

Results from the US technology giants initially brought a sharp sell-off in the share prices of…


A prime buying opportunity?

27/06/2022 · Your Money

Amazon.com shares are down by a third this year. Opportunity knocks, but a battle with Stranger…


More on Aston Martin Lagonda

Episode 7 of the Investor’s Champion Podcast

02/03/2024 · Podcasts

In this episode of the Investor’s Champion Podcast Chris and Lee run through key stock market…


Utter gobbledygook | Tough to value

29/02/2024 · Company Insights

Results from a well-known wealth manager covered here are as confusing as their fees and we…


More on AstraZeneca

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…


More on Burford Capital Ltd

AIM welcomes an exciting new arrival

11/09/2023 · Company Insights

Despite the continuing challenging environment for small caps, it was great to see AIM welcome one…


Shining a light on a superb AIM elder

16/03/2023 · Company Insights

News from AIM covered here include delightfully simple results from one high-quality AIM company, without an adjustment…


More on Diageo

Episode 29 of the Investor’s Champion Podcast

04/08/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Chris and Lee discuss a variety of…


Game delights | Consumer facing weakness | Tech delivers

02/08/2024 · Portfolio

Most of our Ultimate Stocks continue to deliver excellent results although it’s more of a struggle…


More on Fevertree Drinks

Episode 33 of the Investor’s Champion Podcast

15/09/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Lee and Chris focus on news from…


US growth | Legal winner | Dividend delights

13/09/2024 · Company Insights

News covered here includes our assessment of interim results from Fevertree, which disappointed the market, despite…


More on GSK

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on Meta Platforms

Episode 29 of the Investor’s Champion Podcast

04/08/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Chris and Lee discuss a variety of…


Episode 15 of the Investor’s Champion Podcast

27/04/2024 · Podcasts

In this episode of the Investor’s Champion Podcast, Chris and Lee discusss yet more impressive results…


More on Quartix Technologies

Excellent results, but nobody is looking!

21/10/2024 · Company Insights

If you need any encouragement that AIM is more than simply about tax planning, several companies…


Episode 29 of the Investor’s Champion Podcast

04/08/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Chris and Lee discuss a variety of…


More on Relx

Ultimate Stocks company updates: luxurious returns

20/10/2023 · Portfolio

Our Ultimate Stocks portfolio of high-quality companies continue to deliver impressive updates, as you can discover…


Ultimate Stocks: Recovery gathering momentum in 2023

13/02/2023 · Portfolio

In 2022 the Ultimate Stocks Portfolio lost 16% - ahead of its benchmark and many quality…


More on Sage Group

Ultimate Stocks Portfolio: company updates

20/05/2024 · Portfolio

It’s great to comment on some outstanding results from UK-listed constituents of our high-quality Ultimate Stocks…


Ultimate Stocks Portfolio: company updates

30/01/2024 · Portfolio

Updates covered here from our high-quality companies include more restrained growth from the world of luxury…


More on Unilever

Episode 28 of the Investor’s Champion Podcast

27/07/2024 · Podcasts

This episode of the Investors Champion Podcast, touches on the tech sector's recent sell-off, the investment…


Income Boosters: making progress in mixed markets

26/07/2024 · Portfolio

July was a busy month for our high yield Income Boosters portfolio, with five companies reporting during…


More on Vodafone

Income Boosters: a new stock with an 8% yield

06/06/2024 · Portfolio

We’ve added a new high yielder to our income portfolio, replacing a reliable performer that’s come…


Episode 9 of the Investor’s Champion Podcast

16/03/2024 · Podcasts

This episode discusses Bitcoin's surging price, the UK competition authority's probe into the veterinary sector, Trainline's growth and…


More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

More on Alphabet

Knocking the lights out | China slowdown | Tech beats

Episode 30 of the Investor’s Champion Podcast

Game delights | Consumer facing weakness | Tech delivers

Episode 28 of the Investor’s Champion Podcast

More on Amazon

Tech giants take a battering - time to buy?

A prime buying opportunity?

Magical growth

AMZN vs MSFT vs GOOGL

More on Aston Martin Lagonda

Episode 7 of the Investor’s Champion Podcast

Utter gobbledygook | Tough to value

Are automakers really in crisis mode?

The week at a glance: 22 July – results madness

More on AstraZeneca

Overhyped perhaps - but don’t ignore AI!

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

Coronavirus impact: 29 April - surging profits and depression era declines

Global investment round-up: this week’s top stories

More on Burford Capital Ltd

AIM welcomes an exciting new arrival

Shining a light on a superb AIM elder

Coronavirus impact: 1 Oct - usual plethora of positives from Burford, but….

Coronavirus impact: 28 April - soaring share prices from this little lot

More on Diageo

Episode 29 of the Investor’s Champion Podcast

Game delights | Consumer facing weakness | Tech delivers

Ultimate Stocks Portfolio: company updates

Episode 2 of the Investor’s Champion Podcast

More on Fevertree Drinks

Episode 33 of the Investor’s Champion Podcast

US growth | Legal winner | Dividend delights

An unusual AIM company with a whopping dividend

Episode 21 of the Investor’s Champion Podcast

More on GSK

Overhyped perhaps - but don’t ignore AI!

Mega-Trends Portfolio: CRISPR is the future

CRISPR: one of the most important inventions of the century?

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

More on Meta Platforms

Episode 29 of the Investor’s Champion Podcast

Episode 15 of the Investor’s Champion Podcast

Episode 4 of the Investor’s Champion Podcast

Investing in a year of turbulence

More on Quartix Technologies

Excellent results, but nobody is looking!

Episode 29 of the Investor’s Champion Podcast

Sublime subscriptions | Waiting for rate cuts | Scientific scare

Fund raise | Excellent offering | Renewed focus

More on Relx

Ultimate Stocks company updates: luxurious returns

Ultimate Stocks: Recovery gathering momentum in 2023

Ultimate Stocks portfolio: company updates

Class is permanent!

More on Sage Group

Ultimate Stocks Portfolio: company updates

Ultimate Stocks Portfolio: company updates

Episode 2 of the Investor’s Champion Podcast

Ultimate Stocks Portfolio: superior returns

More on Unilever

Episode 28 of the Investor’s Champion Podcast

Income Boosters: making progress in mixed markets

Ultimate Stocks portfolio: company news

Income Boosters: April ‘24 portfolio update

More on Vodafone

Income Boosters: a new stock with an 8% yield

Episode 9 of the Investor’s Champion Podcast

Income Boosters: value for dividend investors

Income Boosters: 9% dividend yield plus a new stock

More Company Insights

Elderly challenges | Demotion | Australian boost
Bonkers Bargains: poised to recover with a new CEO
Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP